Based on this work, the authors suggested that pharmacologic inhibition of retrotransposition activities using antiretroviral drugs might be a way to mitigate the neurotoxic effects of TDP-43 pathology in FTD-ALS patients (Liu et al., 2019). Here, TARDBP is linked to frontotemporal dementia.